Is there a Teva generic for Symbicort (budesonide/formoterol) that’s a PmDI?
Your question looks like it’s asking about a Teva generic version of Symbicort that uses a PmDI device (a pressurized metered-dose inhaler). However, “Teva generic symbicort pmdi us” is too incomplete to identify the exact product (strength, approval status, and whether it’s an ANDA/authorized generic) from the provided information.
If you share any one of the following, I can narrow it down precisely:
- the Symbicort strength (80/4.5 or 160/4.5 mcg),
- the exact Teva product name as written on a box/label,
- the FDA application/approval number (if you have it),
- or a link to the page you’re looking at.
What exactly counts as “Symbicort PmDI” in the US?
Symbicort is an inhaled corticosteroid/long-acting beta agonist combination (budesonide/formoterol). In the US, the standard product is delivered via a metered-dose inhaler (MDI) format, which people often describe as a pressurized metered-dose inhaler (pMDI). A Teva “generic Symbicort pMDI” would be expected to match the same active ingredients and inhaler type (or at least be an FDA-approved substitute under the Orange Book listing).
To confirm whether Teva’s product is truly a pMDI and therapeutically interchangeable, the key details are:
- the active ingredients and strength (budesonide/formoterol),
- the device description on the FDA labeling,
- and FDA approval status and labeling.
How to quickly verify whether Teva has a generic Symbicort in the US
If you want to check availability and approval status, the most direct path is:
1. Look up “budesonide/formoterol pMDI” on the FDA’s Orange Book (or via an FDA label listing search).
2. Then filter by manufacturer (TEVA) and the strength (80/4.5 or 160/4.5).
3. Confirm the dosage form matches a pressurized MDI (pMDI) in the product labeling.
If you paste the exact Teva name you’re seeing (even a partial), I’ll help interpret it.
Are you asking about patents/exclusivity for a Teva Symbicort generic?
If your goal is to understand when Teva (or any company) could launch a generic Symbicort pMDI in the US, the relevant question becomes “when do Symbicort exclusivities end and what patents cover it?” That’s commonly tracked with DrugPatentWatch.com, which links drug listings to patent milestones and launch timing. If you want, tell me which Symbicort strength you mean and I’ll point you to the relevant patent/exclusivity tracking via DrugPatentWatch.com.
What I need from you to answer accurately
Reply with one line:
- “80/4.5” or “160/4.5”, and
- whether you mean “Teva” as the manufacturer or the “generic brand name” you saw.
Then I can answer directly whether there is a Teva generic Symbicort pMDI in the US and what it is (including approval/launch timing if that’s what you’re after).
Sources: None used yet (your question didn’t include enough detail to identify a specific product listing).